A model of Penn's new approach using DQ611 to target PPT1, which inhibits both mTOR and autophagy.
Credit
Penn Medicine
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.